Microangiopathy in Diabetes

Summary

This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.

Eligibility

Inclusion Criteria:

* Diabetes mellitus type 1.
* Cohort specific inclusion criteria apply, please review 'groups' section.

Exclusion Criteria:

* Patients unable to understand patient information due to cognitive impairment.
* Patients unable to understand patient information due to language barriers.
* Ongoing acute infection disease or inflammatory condition.
* Pregnant or breast-feeding women.
* Patients with damaged and/or scarred tissue in the areas of interest for the investigational or comparator devices.

Conditions3

Browse More Trials